Header Logo

Connection

Mark Pollack to Middle Aged

Back to Details
This is a "connection" page, showing publications Mark Pollack has written about Middle Aged.
Mark Pollack
Connection Strength
2.306
Middle Aged
  1. "I knew it was wrong the moment I got the order": A narrative thematic analysis of moral injury in combat veterans. Psychol Trauma. 2019 May; 11(4):396-405.
    View in: PubMed
    Score: 0.060
  2. Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma. Ann Oncol. 2018 01 01; 29(1):250-255.
    View in: PubMed
    Score: 0.059
  3. A randomized, controlled trial of the efficacy of an interoceptive exposure-based CBT for treatment-refractory outpatients with opioid dependence. J Psychoactive Drugs. 2014 Nov-Dec; 46(5):402-11.
    View in: PubMed
    Score: 0.047
  4. A double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorder. Am J Psychiatry. 2014 Jan; 171(1):44-53.
    View in: PubMed
    Score: 0.044
  5. Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial. J Consult Clin Psychol. 2012 Jun; 80(3):404-15.
    View in: PubMed
    Score: 0.040
  6. A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study). Psychother Psychosom. 2012; 81(2):87-97.
    View in: PubMed
    Score: 0.039
  7. Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2011 Jul; 72(7):892-7.
    View in: PubMed
    Score: 0.036
  8. Culturally adapted CBT (CA-CBT) for Latino women with treatment-resistant PTSD: a pilot study comparing CA-CBT to applied muscle relaxation. Behav Res Ther. 2011 Apr; 49(4):275-80.
    View in: PubMed
    Score: 0.036
  9. Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder. Biol Psychiatry. 2010 Feb 15; 67(4):365-70.
    View in: PubMed
    Score: 0.033
  10. Nightmares among Cambodian refugees: the breaching of concentric ontological security. Cult Med Psychiatry. 2009 Jun; 33(2):219-65.
    View in: PubMed
    Score: 0.032
  11. Brain GABA levels in patients with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Apr 30; 33(3):427-34.
    View in: PubMed
    Score: 0.032
  12. Open-label support for duloxetine for the treatment of panic disorder. CNS Neurosci Ther. 2009; 15(1):19-23.
    View in: PubMed
    Score: 0.031
  13. Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies. J Clin Psychopharmacol. 2008 Jun; 28(3):308-16.
    View in: PubMed
    Score: 0.030
  14. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Arch Gen Psychiatry. 2008 May; 65(5):551-62.
    View in: PubMed
    Score: 0.030
  15. Early improvement during duloxetine treatment of generalized anxiety disorder predicts response and remission at endpoint. J Psychiatr Res. 2008 Oct; 42(14):1176-84.
    View in: PubMed
    Score: 0.030
  16. Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy. J Clin Psychiatry. 2008 Mar; 69(3):400-5.
    View in: PubMed
    Score: 0.030
  17. Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings. Psychopharmacology (Berl). 2008 May; 197(4):675-81.
    View in: PubMed
    Score: 0.030
  18. High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: response to treatment with levetiracetam. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 01; 32(3):739-43.
    View in: PubMed
    Score: 0.029
  19. Levetiracetam as adjunctive therapy for refractory anxiety disorders. J Clin Psychiatry. 2007 Jul; 68(7):1010-3.
    View in: PubMed
    Score: 0.028
  20. A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder. Psychopharmacology (Berl). 2007 Oct; 194(2):233-42.
    View in: PubMed
    Score: 0.028
  21. Orthostatic panic as a key Vietnamese reaction to traumatic events: the case of September 11, 2001. Med Anthropol Q. 2007 Mar; 21(1):81-107.
    View in: PubMed
    Score: 0.028
  22. The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder. J Clin Psychopharmacol. 2007 Feb; 27(1):85-8.
    View in: PubMed
    Score: 0.028
  23. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder. Depress Anxiety. 2007; 24(1):1-14.
    View in: PubMed
    Score: 0.027
  24. The relationship of anxiety disorders, anxiety sensitivity and pulmonary dysfunction with dyspnea-related distress and avoidance. J Nerv Ment Dis. 2006 Dec; 194(12):951-7.
    View in: PubMed
    Score: 0.027
  25. The association of comorbid anxiety disorders with suicide attempts and suicidal ideation in outpatients with bipolar disorder. J Psychiatr Res. 2007 Apr-Jun; 41(3-4):255-64.
    View in: PubMed
    Score: 0.027
  26. Orthostatically induced panic attacks among Vietnamese refugees: associated psychopathology, flashbacks, and catastrophic cognitions. Depress Anxiety. 2006; 23(2):113-5.
    View in: PubMed
    Score: 0.026
  27. Neck-focused panic attacks among Cambodian refugees; a logistic and linear regression analysis. J Anxiety Disord. 2006; 20(2):119-38.
    View in: PubMed
    Score: 0.026
  28. A randomized controlled trial of cognitive-behavior therapy for Cambodian refugees with treatment-resistant PTSD and panic attacks: a cross-over design. J Trauma Stress. 2005 Dec; 18(6):617-29.
    View in: PubMed
    Score: 0.025
  29. The selective GABA reuptake inhibitor tiagabine for the treatment of generalized anxiety disorder: results of a placebo-controlled study. J Clin Psychiatry. 2005 Nov; 66(11):1401-8.
    View in: PubMed
    Score: 0.025
  30. Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled study. Biol Psychiatry. 2006 Feb 01; 59(3):211-5.
    View in: PubMed
    Score: 0.025
  31. Fluoxetine for vestibular dysfunction and anxiety: a prospective pilot study. Psychosomatics. 2005 Jul-Aug; 46(4):334-9.
    View in: PubMed
    Score: 0.025
  32. 'The ghost pushes you down': sleep paralysis-type panic attacks in a Khmer refugee population. Transcult Psychiatry. 2005 Mar; 42(1):46-77.
    View in: PubMed
    Score: 0.024
  33. Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients. Int Clin Psychopharmacol. 2005 Jan; 20(1):9-11.
    View in: PubMed
    Score: 0.024
  34. Olfactory-triggered panic attacks among Khmer refugees: a contextual approach. Transcult Psychiatry. 2004 Jun; 41(2):155-99.
    View in: PubMed
    Score: 0.023
  35. Treatment of pharmacotherapy-refractory posttraumatic stress disorder among Cambodian refugees: a pilot study of combination treatment with cognitive-behavior therapy vs sertraline alone. Behav Res Ther. 2003 Nov; 41(11):1271-6.
    View in: PubMed
    Score: 0.022
  36. Combined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorder. J Psychopharmacol. 2003 Sep; 17(3):276-82.
    View in: PubMed
    Score: 0.022
  37. Predictors of outcome following venlafaxine extended-release treatment of DSM-IV generalized anxiety disorder: a pooled analysis of short- and long-term studies. J Clin Psychopharmacol. 2003 Jun; 23(3):250-9.
    View in: PubMed
    Score: 0.021
  38. Predicting panic disorder among patients with chest pain: an analysis of the literature. Psychosomatics. 2003 May-Jun; 44(3):222-36.
    View in: PubMed
    Score: 0.021
  39. Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder. J Psychiatr Res. 2002 Jul-Aug; 36(4):229-36.
    View in: PubMed
    Score: 0.020
  40. Quality of life in social anxiety disorder compared with panic disorder and the general population. Psychiatr Serv. 2002 Jun; 53(6):714-8.
    View in: PubMed
    Score: 0.020
  41. Hypothyroidism and hyperthyroidism in anxiety disorders revisited: new data and literature review. J Affect Disord. 2002 May; 69(1-3):209-17.
    View in: PubMed
    Score: 0.020
  42. Citalopram for social phobia: a clinical case series. Prog Neuropsychopharmacol Biol Psychiatry. 2001 Oct; 25(7):1469-74.
    View in: PubMed
    Score: 0.019
  43. The anxiety sensitivity index: item analysis and suggestions for refinement. J Pers Assess. 2001 Oct; 77(2):272-94.
    View in: PubMed
    Score: 0.019
  44. Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry. 2001 May; 62(5):350-7.
    View in: PubMed
    Score: 0.018
  45. The Substance Use Intervention Team: A Preliminary Analysis of a Population-level Strategy to Address the Opioid Crisis at an Academic Health Center. J Addict Med. 2019 Nov/Dec; 13(6):460-463.
    View in: PubMed
    Score: 0.017
  46. Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis. J Anxiety Disord. 2019 12; 68:102149.
    View in: PubMed
    Score: 0.017
  47. Feasibility of a 3-week intensive treatment program for service members and veterans with PTSD. Psychol Trauma. 2020 May; 12(4):422-430.
    View in: PubMed
    Score: 0.016
  48. Collaborative Care for Depression of Adults and Adolescents: Measuring the Effectiveness of Screening and Treatment Uptake. Psychiatr Serv. 2019 07 01; 70(7):604-607.
    View in: PubMed
    Score: 0.016
  49. A placebo-controlled pilot study of a wearable morning bright light treatment for probable PTSD. Depress Anxiety. 2019 07; 36(7):617-624.
    View in: PubMed
    Score: 0.016
  50. An Open Trial of Morning Bright Light Treatment Among US Military Veterans with Chronic Low Back Pain: A Pilot Study. Pain Med. 2019 04 01; 20(4):770-778.
    View in: PubMed
    Score: 0.016
  51. Evaluating patterns and predictors of symptom change during a three-week intensive outpatient treatment for veterans with PTSD. BMC Psychiatry. 2018 07 27; 18(1):242.
    View in: PubMed
    Score: 0.015
  52. Gabapentin as a potential treatment for anxiety disorders. Am J Psychiatry. 1998 Jul; 155(7):992-3.
    View in: PubMed
    Score: 0.015
  53. Rate of improvement during cognitive-behavioral group treatment for panic disorder. Behav Res Ther. 1998 Jul-Aug; 36(7-8):665-73.
    View in: PubMed
    Score: 0.015
  54. How do clinicians respond to patients who miss appointments? J Clin Psychiatry. 1998 Jun; 59(6):330-8; quiz 339-40.
    View in: PubMed
    Score: 0.015
  55. Negative posttraumatic cognitions among military sexual trauma survivors. J Affect Disord. 2018 10 01; 238:88-93.
    View in: PubMed
    Score: 0.015
  56. Anxiety sensitivity moderates drug cravings in response to induced negative affect in opioid dependent outpatients. Addict Behav. 2018 09; 84:75-78.
    View in: PubMed
    Score: 0.015
  57. Nefazodone for social phobia: a clinical case series. Depress Anxiety. 1998; 8(3):131-3.
    View in: PubMed
    Score: 0.015
  58. Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction. Ann Clin Psychiatry. 1997 Dec; 9(4):241-5.
    View in: PubMed
    Score: 0.015
  59. Negative Posttrauma Cognitions Mediate the Association Between Morally Injurious Events and Trauma-Related Psychopathology in Treatment-Seeking Veterans. J Trauma Stress. 2017 12; 30(6):698-703.
    View in: PubMed
    Score: 0.015
  60. Characteristics of veterans and military service members who endorse causing harm, injury, or death to others in the military. Psychol Trauma. 2018 May; 10(3):352-359.
    View in: PubMed
    Score: 0.014
  61. Selective encoding of threat in panic disorder: application of a dual priming paradigm. Behav Res Ther. 1997 Jun; 35(6):543-9.
    View in: PubMed
    Score: 0.014
  62. The effect of mindfulness meditation training on biological acute stress responses in generalized anxiety disorder. Psychiatry Res. 2018 04; 262:328-332.
    View in: PubMed
    Score: 0.014
  63. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone. J Clin Psychiatry. 1997; 58 Suppl 11:19-23.
    View in: PubMed
    Score: 0.014
  64. Relationship of antecedent stressful life events to childhood and family history of anxiety and the course of panic disorder. J Affect Disord. 1996 Nov 25; 41(2):135-9.
    View in: PubMed
    Score: 0.014
  65. RANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER. Depress Anxiety. 2016 08; 33(8):737-45.
    View in: PubMed
    Score: 0.013
  66. A Pilot Study of Tailored Cognitive-Behavioral Resilience Training for Trauma Survivors With Subthreshold Distress. J Trauma Stress. 2016 06; 29(3):268-72.
    View in: PubMed
    Score: 0.013
  67. Prevalence of panic in patients referred for pulmonary function testing at a major medical center. Am J Psychiatry. 1996 Jan; 153(1):110-3.
    View in: PubMed
    Score: 0.013
  68. Venlafaxine for panic disorder: results from a double-blind, placebo-controlled study. Psychopharmacol Bull. 1996; 32(4):667-70.
    View in: PubMed
    Score: 0.013
  69. ADULT ANXIETY DISORDERS IN RELATION TO TRAIT ANXIETY AND PERCEIVED STRESS IN CHILDHOOD. Psychol Rep. 2015 Oct; 117(2):473-89.
    View in: PubMed
    Score: 0.012
  70. Brain connectomics predict response to treatment in social anxiety disorder. Mol Psychiatry. 2016 May; 21(5):680-5.
    View in: PubMed
    Score: 0.012
  71. Cognitive behavior therapy for treatment-refractory panic disorder. J Clin Psychiatry. 1994 May; 55(5):200-5.
    View in: PubMed
    Score: 0.011
  72. Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo. J Affect Disord. 1994 Apr; 30(4):273-81.
    View in: PubMed
    Score: 0.011
  73. Treatment of fluoxetine-induced sexual dysfunction with bupropion: a case report. Ann Clin Psychiatry. 1994 Mar; 6(1):13-5.
    View in: PubMed
    Score: 0.011
  74. The human ortholog of acid-sensing ion channel gene ASIC1a is associated with panic disorder and amygdala structure and function. Biol Psychiatry. 2014 Dec 01; 76(11):902-10.
    View in: PubMed
    Score: 0.011
  75. De novo fear conditioning across diagnostic groups in the affective disorders: evidence for learning impairments. Behav Ther. 2014 Sep; 45(5):619-29.
    View in: PubMed
    Score: 0.011
  76. Randomized controlled trial of mindfulness meditation for generalized anxiety disorder: effects on anxiety and stress reactivity. J Clin Psychiatry. 2013 Aug; 74(8):786-92.
    View in: PubMed
    Score: 0.011
  77. Two weeks of pretreatment with escitalopram facilitates extinction learning in healthy individuals. Hum Psychopharmacol. 2013 Sep; 28(5):447-56.
    View in: PubMed
    Score: 0.011
  78. Development of a brief version of the Social Phobia Inventory using item response theory: the Mini-SPIN-R. Behav Ther. 2013 Dec; 44(4):651-61.
    View in: PubMed
    Score: 0.011
  79. Voxel-based morphometric gray matter correlates of posttraumatic stress disorder. J Anxiety Disord. 2013 May; 27(4):413-9.
    View in: PubMed
    Score: 0.011
  80. Loving-Kindness Meditation practice associated with longer telomeres in women. Brain Behav Immun. 2013 Aug; 32:159-63.
    View in: PubMed
    Score: 0.011
  81. Adjunctive yohimbine for treatment in refractory depression. Biol Psychiatry. 1993 Feb 01; 33(3):220-1.
    View in: PubMed
    Score: 0.010
  82. Augmentation of exposure therapy with post-session administration of D-cycloserine. J Psychiatr Res. 2013 Feb; 47(2):168-74.
    View in: PubMed
    Score: 0.010
  83. Plasma oxytocin immunoreactive products and response to trust in patients with social anxiety disorder. Depress Anxiety. 2012 Nov; 29(11):924-30.
    View in: PubMed
    Score: 0.010
  84. Sexual HIV risk behaviors in a treatment-refractory opioid-dependent sample. J Psychoactive Drugs. 2012 Jul-Aug; 44(3):237-42.
    View in: PubMed
    Score: 0.010
  85. Avoidant personality disorder in individuals with generalized social anxiety disorder: what does it add? J Anxiety Disord. 2012 Aug; 26(6):665-72.
    View in: PubMed
    Score: 0.010
  86. Mood regulation and quality of life in social anxiety disorder: an examination of generalized expectancies for negative mood regulation. J Anxiety Disord. 2012 Apr; 26(3):435-41.
    View in: PubMed
    Score: 0.010
  87. Treatment change of somatic symptoms and cultural syndromes among Cambodian refugees with PTSD. Depress Anxiety. 2012 Feb; 29(2):147-54.
    View in: PubMed
    Score: 0.010
  88. Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial. J Clin Psychiatry. 2012 Mar; 73(3):353-7.
    View in: PubMed
    Score: 0.009
  89. Understanding the relationship of perceived social support to post-trauma cognitions and posttraumatic stress disorder. J Anxiety Disord. 2011 Dec; 25(8):1072-8.
    View in: PubMed
    Score: 0.009
  90. Pilot outreach services to homebound agoraphobic patients. Hosp Community Psychiatry. 1991 Mar; 42(3):315-7.
    View in: PubMed
    Score: 0.009
  91. The role of anxiety sensitivity in sleep disturbance in panic disorder. J Anxiety Disord. 2011 May; 25(4):536-8.
    View in: PubMed
    Score: 0.009
  92. Effect of acute posttrauma propranolol on PTSD outcome and physiological responses during script-driven imagery. CNS Neurosci Ther. 2012 Jan; 18(1):21-7.
    View in: PubMed
    Score: 0.009
  93. Anger, PTSD, and the nuclear family: a study of Cambodian refugees. Soc Sci Med. 2009 Nov; 69(9):1387-94.
    View in: PubMed
    Score: 0.008
  94. Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder. Depress Anxiety. 2009; 26(5):447-55.
    View in: PubMed
    Score: 0.008
  95. A comparison of emotional approach coping (EAC) between individuals with anxiety disorders and nonanxious controls. CNS Neurosci Ther. 2009; 15(2):100-6.
    View in: PubMed
    Score: 0.008
  96. Mechanisms of efficacy of CBT for Cambodian refugees with PTSD: improvement in emotion regulation and orthostatic blood pressure response. CNS Neurosci Ther. 2009; 15(3):255-63.
    View in: PubMed
    Score: 0.008
  97. Childhood maltreatment linked to greater symptom severity and poorer quality of life and function in social anxiety disorder. Depress Anxiety. 2009; 26(11):1027-32.
    View in: PubMed
    Score: 0.008
  98. Aripiprazole as augmentation treatment of refractory generalized anxiety disorder and panic disorder. CNS Spectr. 2008 Jun; 13(6):522-7.
    View in: PubMed
    Score: 0.008
  99. A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders. Brain Stimul. 2008 Apr; 1(2):112-21.
    View in: PubMed
    Score: 0.007
  100. Anhedonic ejaculation with desipramine. Int J Psychiatry Med. 1988; 18(1):85-8.
    View in: PubMed
    Score: 0.007
  101. Examination of the decline in symptoms of anxiety and depression in generalized anxiety disorder: impact of anxiety sensitivity on response to pharmacotherapy. Depress Anxiety. 2008; 25(2):167-71.
    View in: PubMed
    Score: 0.007
  102. Ataque de nervios: relationship to anxiety sensitivity and dissociation predisposition. Depress Anxiety. 2008; 25(6):489-95.
    View in: PubMed
    Score: 0.007
  103. The panic attack-posttraumatic stress disorder model: applicability to orthostatic panic among Cambodian refugees. Cogn Behav Ther. 2008; 37(2):101-16.
    View in: PubMed
    Score: 0.007
  104. Oxytocin levels in social anxiety disorder. CNS Neurosci Ther. 2008; 14(3):165-70.
    View in: PubMed
    Score: 0.007
  105. Complicated grief and impaired sleep in patients with bipolar disorder. Bipolar Disord. 2007 Dec; 9(8):913-7.
    View in: PubMed
    Score: 0.007
  106. Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women's Health Initiative Observational Study. Arch Gen Psychiatry. 2007 Oct; 64(10):1153-60.
    View in: PubMed
    Score: 0.007
  107. Clonazepam: a review of open clinical trials. J Clin Psychiatry. 1987 Oct; 48 Suppl:12-5.
    View in: PubMed
    Score: 0.007
  108. A detailed examination of cytokine abnormalities in Major Depressive Disorder. Eur Neuropsychopharmacol. 2008 Mar; 18(3):230-3.
    View in: PubMed
    Score: 0.007
  109. Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States. Curr Med Res Opin. 2007 Jun; 23(6):1431-43.
    View in: PubMed
    Score: 0.007
  110. Clonazepam in the treatment of panic disorder and agoraphobia. Psychopharmacol Bull. 1987; 23(1):141-4.
    View in: PubMed
    Score: 0.007
  111. Cross-cultural differences in somatic presentation in patients with generalized anxiety disorder. J Nerv Ment Dis. 2006 Dec; 194(12):962-6.
    View in: PubMed
    Score: 0.007
  112. Panic attacks, daily life ischemia, and chest pain in postmenopausal women. Psychosom Med. 2006 Nov-Dec; 68(6):824-32.
    View in: PubMed
    Score: 0.007
  113. Clonazepam in the treatment of panic disorder and agoraphobia: a one-year follow-up. J Clin Psychopharmacol. 1986 Oct; 6(5):302-4.
    View in: PubMed
    Score: 0.007
  114. Understanding the link between anxiety symptoms and suicidal ideation and behaviors in outpatients with bipolar disorder. J Affect Disord. 2007 Jan; 97(1-3):91-9.
    View in: PubMed
    Score: 0.007
  115. Oculocutaneous albinism and schizophrenia. Biol Psychiatry. 1986 Jul; 21(8-9):830-3.
    View in: PubMed
    Score: 0.007
  116. Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders. Br J Psychiatry. 2006 Jul; 189:20-5.
    View in: PubMed
    Score: 0.007
  117. Assessment of posttraumatic stress disorder in Cambodian refugees using the Clinician-Administered PTSD Scale: psychometric properties and symptom severity. J Trauma Stress. 2006 Jun; 19(3):405-9.
    View in: PubMed
    Score: 0.007
  118. Methadone maintenance improves cognitive performance after two months of treatment. Exp Clin Psychopharmacol. 2006 May; 14(2):157-64.
    View in: PubMed
    Score: 0.007
  119. Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol Psychiatry. 2006 Sep 01; 60(5):432-5.
    View in: PubMed
    Score: 0.007
  120. Anxiety sensitivity among Cambodian refugees with panic disorder: A factor analytic investigation. J Anxiety Disord. 2006; 20(3):281-95.
    View in: PubMed
    Score: 0.006
  121. Anxiety sensitivity in traumatized Cambodian refugees: a discriminant function and factor analytic investigation. Behav Res Ther. 2005 Dec; 43(12):1631-43.
    View in: PubMed
    Score: 0.006
  122. Treatment-emergent incontinence with lithium. J Clin Psychiatry. 1985 Oct; 46(10):444-5.
    View in: PubMed
    Score: 0.006
  123. Complicated grief and its correlates in patients with bipolar disorder. J Clin Psychiatry. 2005 Sep; 66(9):1105-10.
    View in: PubMed
    Score: 0.006
  124. Childhood antecedents to panic disorder in referred and nonreferred adults. J Child Adolesc Psychopharmacol. 2005 Aug; 15(4):549-61.
    View in: PubMed
    Score: 0.006
  125. Panic disorder and bipolar disorder: anxiety sensitivity as a potential mediator of panic during manic states. J Affect Disord. 2005 Jul; 87(1):101-5.
    View in: PubMed
    Score: 0.006
  126. Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants. Biol Psychiatry. 2005 Jun 01; 57(11):1467-73.
    View in: PubMed
    Score: 0.006
  127. Propranolol and depression revisited: three cases and a review. J Nerv Ment Dis. 1985 Feb; 173(2):118-9.
    View in: PubMed
    Score: 0.006
  128. Sleep paralysis among Cambodian refugees: association with PTSD diagnosis and severity. Depress Anxiety. 2005; 22(2):47-51.
    View in: PubMed
    Score: 0.006
  129. Parental predictors of pediatric panic disorder/agoraphobia: a controlled study in high-risk offspring. Depress Anxiety. 2005; 22(3):114-20.
    View in: PubMed
    Score: 0.006
  130. Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD. J Clin Psychopharmacol. 2004 Oct; 24(5):512-20.
    View in: PubMed
    Score: 0.006
  131. Olfactory-triggered panic attacks among Cambodian refugees attending a psychiatric clinic. Gen Hosp Psychiatry. 2004 Sep-Oct; 26(5):390-7.
    View in: PubMed
    Score: 0.006
  132. White matter hyperintensities in subjects with cocaine and opiate dependence and healthy comparison subjects. Psychiatry Res. 2004 Jul 30; 131(2):135-45.
    View in: PubMed
    Score: 0.006
  133. Moderating effects of major depression on patterns of comorbidity in patients with panic disorder. Psychiatry Res. 2004 Apr 30; 126(2):143-9.
    View in: PubMed
    Score: 0.006
  134. Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study. J Clin Psychopharmacol. 2004 Apr; 24(2):141-9.
    View in: PubMed
    Score: 0.006
  135. Prevalence and correlates of panic attacks in postmenopausal women: results from an ancillary study to the Women's Health Initiative. Arch Intern Med. 2003 Sep 22; 163(17):2041-50.
    View in: PubMed
    Score: 0.005
  136. Clinical significance of serum antibody responses to exotoxin A and type-specific lipopolysaccharides in patients with Pseudomonas aeruginosa infections. Am J Med. 1983 Jun; 74(6):980-7.
    View in: PubMed
    Score: 0.005
  137. Valproic acid for the treatment of social anxiety disorder. Int Clin Psychopharmacol. 2003 May; 18(3):169-72.
    View in: PubMed
    Score: 0.005
  138. Somatic panic-attack equivalents in a community sample of Rwandan widows who survived the 1994 genocide. Psychiatry Res. 2003 Jan 25; 117(1):1-9.
    View in: PubMed
    Score: 0.005
  139. Ropinirole for antidepressant-induced sexual dysfunction. Int Clin Psychopharmacol. 2002 Nov; 17(6):307-10.
    View in: PubMed
    Score: 0.005
  140. Treatment of muscle contraction headache: Micrainin vs. aspirin. Headache. 1982 May; 22(3):101-9.
    View in: PubMed
    Score: 0.005
  141. Sertraline treatment of panic disorder: results of a long-term study. Acta Psychiatr Scand. 2001 Oct; 104(4):289-98.
    View in: PubMed
    Score: 0.005
  142. Childhood history of anxiety disorders among adults with social phobia: rates, correlates, and comparisons with patients with panic disorder. Depress Anxiety. 2001; 14(4):209-13.
    View in: PubMed
    Score: 0.005
  143. Placebo-controlled study of gabapentin treatment of panic disorder. J Clin Psychopharmacol. 2000 Aug; 20(4):467-71.
    View in: PubMed
    Score: 0.004
  144. Empirically supported treatments for panic disorder: costs, benefits, and stepped care. J Consult Clin Psychol. 2000 Aug; 68(4):556-63.
    View in: PubMed
    Score: 0.004
  145. Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder. Am J Psychiatry. 2000 Jun; 157(6):968-74.
    View in: PubMed
    Score: 0.004
  146. Group cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: a clinical case series. Behav Res Ther. 1999 Aug; 37(8):763-70.
    View in: PubMed
    Score: 0.004
  147. Cerebral phosphorus metabolite abnormalities in opiate-dependent polydrug abusers in methadone maintenance. Psychiatry Res. 1999 Jun 30; 90(3):143-52.
    View in: PubMed
    Score: 0.004
  148. Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study. Am J Psychiatry. 1999 May; 156(5):756-60.
    View in: PubMed
    Score: 0.004
  149. Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man. J Clin Invest. 1979 Feb; 63(2):276-86.
    View in: PubMed
    Score: 0.004
  150. Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group. Am J Psychiatry. 1998 Nov; 155(11):1570-7.
    View in: PubMed
    Score: 0.004
  151. Sertraline effects on dyspnea in patients with obstructive airways disease. Psychosomatics. 1998 Jan-Feb; 39(1):24-9.
    View in: PubMed
    Score: 0.004
  152. Panic disorder in emergency ward patients with chest pain. J Nerv Ment Dis. 1997 Apr; 185(4):274-6.
    View in: PubMed
    Score: 0.003
  153. Prevalence and correlates of anger attacks: a two site study. J Affect Disord. 1996 Jun 20; 39(1):31-8.
    View in: PubMed
    Score: 0.003
  154. EEG abnormalities in patients with atypical panic attacks. J Clin Psychiatry. 1995 Aug; 56(8):358-62.
    View in: PubMed
    Score: 0.003
  155. The relationship of alprazolam and clonazepam dose to steady-state concentration in plasma. J Clin Psychopharmacol. 1994 Aug; 14(4):274-6.
    View in: PubMed
    Score: 0.003
  156. Sleep panic attacks: an association with childhood anxiety and adult psychopathology. Biol Psychiatry. 1994 Jul 01; 36(1):57-60.
    View in: PubMed
    Score: 0.003
  157. Predicting prospective episodes of depression in patients with panic disorder: a longitudinal study. J Consult Clin Psychol. 1994 Apr; 62(2):359-65.
    View in: PubMed
    Score: 0.003
  158. Childhood history of anxiety in adults with panic disorder: association with anxiety sensitivity and comorbidity. Harv Rev Psychiatry. 1994 Jan-Feb; 1(5):288-93.
    View in: PubMed
    Score: 0.003
  159. Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder. Am J Psychiatry. 1993 Oct; 150(10):1485-90.
    View in: PubMed
    Score: 0.003
  160. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo. J Affect Disord. 1993 May; 28(1):27-38.
    View in: PubMed
    Score: 0.003
  161. Cholera in Piura, Peru: a modern urban epidemic. J Infect Dis. 1992 Dec; 166(6):1429-33.
    View in: PubMed
    Score: 0.003
  162. Alcohol dependence in panic disorder patients. J Psychiatr Res. 1992 Jan; 26(1):29-38.
    View in: PubMed
    Score: 0.002
  163. Major depression in panic disorder patients with comorbid social phobia. J Affect Disord. 1991 Jul; 22(3):171-7.
    View in: PubMed
    Score: 0.002
  164. The antidepressant potential of oral S-adenosyl-l-methionine. Acta Psychiatr Scand. 1990 May; 81(5):432-6.
    View in: PubMed
    Score: 0.002
  165. Neuroendocrine effects of S-adenosyl-L-methionine, a novel putative antidepressant. J Psychiatr Res. 1990; 24(2):177-84.
    View in: PubMed
    Score: 0.002
  166. Fluoxetine-induced sexual dysfunction. J Clin Psychiatry. 1990 Jan; 51(1):25-7.
    View in: PubMed
    Score: 0.002
  167. Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report. J Clin Psychiatry. 1989 Dec; 50(12):447-9.
    View in: PubMed
    Score: 0.002
  168. Acute distress after switch from Norpramin to generic desipramine. Am J Psychiatry. 1989 Jan; 146(1):122.
    View in: PubMed
    Score: 0.002
  169. An open-label pilot study of oral S-adenosylmethionine in major depression. An interim report. Ala J Med Sci. 1988 Jul; 25(3):301-6.
    View in: PubMed
    Score: 0.002
  170. An open-label pilot study of oral S-adenosyl-L-methionine in major depression: interim results. Psychopharmacol Bull. 1988; 24(1):189-94.
    View in: PubMed
    Score: 0.002
  171. Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial. J Clin Psychiatry. 1987 Oct; 48 Suppl:16-21.
    View in: PubMed
    Score: 0.002
  172. Orthostatic hypotension and antidepressant pharmacotherapy. Psychopharmacol Bull. 1987; 23(1):182-6.
    View in: PubMed
    Score: 0.002
  173. Enhancement of ECT benefit by yohimbine. J Clin Psychiatry. 1986 Oct; 47(10):508-10.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.